It has been a while since we checked in on the Altarum reports which track health care prices, utilization and spending trends. In October the firm released its latest Health Sector Trend Report. (Altarum Reports) Health spending growth through August 2017 was 4.7% year-over-year, a range it has stayed in all year and consistent with year-over-year growth of 4.6% in 2016. Health care services growth, however, appears to be decelerating, with 4.9% growth in 2016 compared to 4.5% in the first half of 2016, and a 4.1% increase in August of 2017. This sector includes physician and hospital services. Prescription drug spending rises also seem to be slowing, with 5% growth in 2016 compared to 3.9% in August. On the other hand, the cost of administration and profits is rising rapidly, from 3.4% in 2016 to a projected 7.9% in 2017. Much of the slowdown in spending is due to muted price growth, which was 2.2% year-over-year in the fourth quarter of 2016 and is 1.3% in the third quarter of 2017. Both physician and hospital price rises have been very slow, in the 1% range, while even drug price increases have slowed, from 6.4% in 2016’s fourth quarter to 2.8% in 2017 Q4. Other Altarum briefs suggest that utilization rises have also been contained, although they are disproportionately accounting for the spending growth. This is very good news for companies and the overall economy. While the rate of health care spending is above that of general economic growth, any reduction is helpful. It is unclear if there are specific tactics which are helping with this moderation of growth, but the pressure needs to be maintained, especially on the price front.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Two health care firms owned by private equity firms are merging in a transaction supposedly valued at $3 billion. HealthComp administers self-funded plans for employers and other groups and Virgin...
September 27, 2023
NextGen, an electronic medical records firm, is being put out of its public company misery, as a PE firm will pay $1.6 billion for the one-time high-flier.
September 7, 2023
A number of companies which attracted large financing rounds during the epidemic have imploded when reality set in. The latest is Cano Health, which is a little surprising since it...
August 15, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace